Results from the DELIVER and DAPA-HF phase III trials demonstrate AstraZeneca’s dapagliflozin’ efficacy in heart failure regardless of ejection fraction. It reached a statistically significant and clinically meaningful reduction in the primary...
Akums Drugs & Pharmaceuticals Ltd acquired the license to manufacture and commercialise Bempedoic acid tablet, the drug which is used for treating high LDL-cholesterol conditions that’s indicative of cardiovascular diseases...
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said on Friday...
The development of molecular formulations which become drugs for treating diseases is at the center of the pharmaceutical industry
The 2020s changed the home healthcare industry forever. The Home Medical Equipment (HME) segment of that industry is under more strain than ever. The increase in demand coupled with staffing shortages revealed critical faults in the billing process f
The United States Food and Drug Administration (USFDA) has granted final approval to Glenmark Pharmaceuticals Inc., USA (Glenmark) for Abiraterone Acetate Tablets...
Biocon Biologics, a subsidiary of biopharmaceutical major Biocon and Viatris, an American global healthcare company launched Abevmy (bBevacizumab) , the oncology biosimilar in Canada...
Dr Reddy's Laboratories is hoping to go to a regulator for its single-dose Sputnik Light jab as booster dose for approvals by June-end or early July, a senior official of the city- based drug-maker said on Thursday. Deepak Sapra, CEO...
Dr Reddy's Laboratories on Thursday said its consolidated net profit for the quarter ended March 2022 dropped to 75.85 per cent to Rs 87.5 crore, compared with Rs 362.4 crore in the same quarter last year...
The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about...
, CDSCO.jpg)
